Why has Cochlear (ASX:COH) plunged ~40%
Cochlear (ASX: COH) Shares Crash almost 40% — Biggest Drop Since 1995 IPO
Cochlear Ltd (ASX: COH) has suffered its largest single-day share price fall in more than 30 years, plunging as much as 39% in early Sydney trading on Wednesday April 22 — the biggest decline since the company’s initial public offering in 1995.
What triggered the collapse? Cochlear dramatically cut its full-year profit guidance, now forecasting underlying net profit of A$290 million to A$330 million. The company had previously guided to the low end of A$435 million to A$460 million — implying a downgrade of more than 30% at the midpoint.
What is driving the profit warning? Cochlear cited a sharp deterioration in consumer sentiment in key markets, particularly the United States, which it said has reached historic lows. The company flagged that weakening sentiment is directly affecting discretionary healthcare decisions among adults and seniors — the core demographic for implantable hearing devices — creating near-term demand uncertainty.
How is COH trading right now? Cochlear shares are trading at $104.50, down $63.40 on the day, with heavy selling pressure weighing on this previously much revered stock.
What does this mean for the sector? The profit warning signals that even premium medical device companies with strong long-term fundamentals are not immune to US consumer confidence weakness. Elective and discretionary healthcare spending — particularly high-cost procedures like cochlear implants — is proving more cyclically sensitive than the market had previously assumed.
- We see no reason to catch this falling knife until further notice.
